Latest Bacterial diseases Stories
Higher Infection Rates of Tick-Borne Diseases Occur in Children Ages 2-14 Making Them a Prime Target for Ticks during Their Summer Camp Vacations. New York, NY (PRWEB) June 14, 2012 School’s out and it’s almost time to send the kids off to camp. Parents across the country are packing travel bags filled with swim goggles, sunscreen and other summertime necessities for their children, but one of the most important things parents need to keep in mind as their young ones head off to...
NAPERVILLE, Ill., June 14, 2012 /PRNewswire/ -- Phigenics LLC, the water services company who is revolutionizing water management with smart analytics software and innovative biological hazard analyses, announced today that it is expanding access to its patented Legionella testing technology to the global water treatment industry. Qualified water treatment providers, consultants, equipment suppliers and analytical laboratories are invited to participate as members of a Value Added...
SWIFTWATER, Pa. and WHITE PLAINS, N.Y., June 13, 2012 /PRNewswire/ -- As health departments across the country report record numbers of pertussis cases, the results of a new survey of American adults released today reveal that most parents aren't asking adults close to their infants and young children to get an adult pertussis booster vaccine, yet they do ask them to follow other basic precautions to safeguard their children's health. The survey was conducted online in May 2012 by...
HUBBARD, Ohio, June 13, 2012 /PRNewswire/ -- NanoLogix (OTC Markets:NNLX) announced today its R&D team in collaboration with University of Texas Health Science Center - Houston (UTHSC-Houston) researchers, are developing a multi-well, microplate reader variant of the company's BioNanoFilter (BNF) diagnostics for use in large volume laboratory environments. Early analysis of the multi-well plates shows exceptionally fast live-threat results similar to the company's standard BNF...
Scientists have found new genetic information that shows how harmful bacteria cause the acute diarrheal disease shigellosis, which kills more than a million people worldwide each year. The research, which could lead to the development of future treatments, was published today in the journal PLoS ONE. The study was led by Ohio University scientist Erin Murphy and doctoral student William Broach, with contributions from University of Nevada, Las Vegas and University of Texas at Austin...
Hospitalization rates in New York City for patients with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), a potentially deadly bacterial infection that is resistant to antibiotic treatment, more than tripled between 1997 and 2006, according to a report published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. Most cases of MRSA are acquired in hospitals, nursing homes, or other...
Circulation study from Children's National Medical Center provides recommendations for preventing treatable condition Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation. The study, conducted by cardiologists from Children's National Medical Center, is the largest single-population study in Africa. The August...
SAN FRANCISCO, June 12, 2012 /PRNewswire/ -- Medizone International, Inc. (The Company) (MZEI:OB) (MZEI:QB) announced today that in achieving 100% kill rates with TB in three successive trials, it had achieved another important milestone in its understanding of the antimicrobial limits of its recently launched disinfection technology, AsepticSure(TM). Dr. Michael E Shannon, President of Medizone International, stated, "With one third of the world's population currently infected...
AUSTIN, Texas, June 12, 2012 /PRNewswire/ -- Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced positive top-line data from its AeroVanc Phase I clinical study in patients with cystic fibrosis (CF). AeroVanc, a dry powder formulation of vancomycin, is the first inhaled antibiotic being developed for the treatment of respiratory...
AUSTIN, Texas, June 12, 2012 /PRNewswire/ -- Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced that it has raised $8.6 million in the first closing of a Series B round of financing. The Keiretsu Forum, comprising accredited private equity investors, led the financing with participation from Savara's existing investors. Savara will use the proceeds...
Latest Bacterial diseases Reference Libraries
Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...
Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...
Streptococcus pyogenes is a spherical, Gram-positive bacterium is the cause of Group A streptococcal infections. It displays streptococcal group A antigen on its cell wall. When it is cultured on blood agar plates it produces large zones of beta-hemolysis. They are catalase-negative and in ideal conditions it has an incubation period of about 1-3 days. It is an infrequent part of the skin flora. It is the cause of many important human diseases, ranging from mild superficial skin infections...
Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...
Rickettsia rickettsii is a gram-negative bacterium native to the New World and causes the malady known as Rocky Mountain spotted fever (RMSF). It is transmitted through the bit of an infected tick when it feeds on animals and humans. Humans are not necessary hosts in the rickettsia-tick life cycle but they can be. S. Burt Wolbach created the first detailed description of the etiologic agent in 1919. He recognized it as an intracellular bacterium seen most frequently in endothelial cells....
